Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02068157 · OUTCOME

Serum Alkaline DNase (SADA) Activity

Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer · Source last updated 2017-10-11

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
Up to 12 months

What was measured

SADA activity will be correlated with tumor response according to the guidelines of the revised Response Criteria in Solid Tumors 1.1.

Analysis population: The published assay could not be validated in murine samples. As such, no human samples were analyzed.

Groups in this outcome

Treatment (Porfimer Sodium, Image-guided I-PDT)

Patients receive porfimer sodium IV over 3-5 minutes on day 0. Patients then undergo image-guided I-PDT on day 2. Laboratory Biomarker Analysis: Correlative studies Photodynamic Therapy: Undergo image-guided I-PDT Porfimer Sodium: Given IV

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Treatment (Porfimer Sodium, Image-guided I-PDT)0

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denoms
  1. counts
    1. group Id
      OG000
      value
      0
    units
    Participants
description
SADA activity will be correlated with tumor response according to the guidelines of the revised Response Criteria in Solid Tumors 1.1.
groups
  1. description
    Patients receive porfimer sodium IV over 3-5 minutes on day 0. Patients then undergo image-guided I-PDT on day 2. Laboratory Biomarker Analysis: Correlative studies Photodynamic Therapy: Undergo image-guided I-PDT Porfimer Sodium: Given IV
    id
    OG000
    title
    Treatment (Porfimer Sodium, Image-guided I-PDT)
population Description
The published assay could not be validated in murine samples. As such, no human samples were analyzed.
reporting Status
POSTED
time Frame
Up to 12 months
title
Serum Alkaline DNase (SADA) Activity
type
SECONDARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice